The FebriDx test targets CRP and Myxovirus resistance protein A, where the latter is a marker of interferon-induced antiviral host response, and has been found to have a high accuracy in terms of indicating the presence of a viral infection in hospitalized adults with SARS-CoV-2 (37). This evidence concerns the gene CRP and viral infectious disease.